Trading Signals: BCRX Stock Price Prediction and Forecast (Tue. Sep. 2, 2003 - Wed. Sep. 27, 2023)(BioCryst Pharmaceuticals, Inc.)
| BCRX latest price $11.1500 (3.1%) ($11.1500 - $11.1500) on Thu. Dec. 22, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.7% (three month average) | RSI | 30 | Latest Price | $11.1500(3.1%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | BCRX advances 0.6% a day on average for past five trading days. | Weekly Trend | BCRX declines -1.8% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support BCRX advance at 0% a week (0% probability) BND(19%) URA(17%) BLOK(16%) XLK(16%) VUG(14%) | Factors Impacting BCRX price | BCRX will decline at least -1.85% in a week (0% probabilities). SMH(-28%) ARKG(-22%) VIXM(-9%) SHY(-8%) BWX(-8%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.85% (StdDev 3.7%) | Hourly BBV | 2.9 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $-4.31(-138.65%) | Resistance Level | $11.41 | 5 Day Moving Average | $10.85(2.76%) | 10 Day Moving Average | $10.9(2.29%) | 20 Day Moving Average | $11.41(-2.28%) | To recent high | -21.6% | To recent low | 6.5% | Market Cap | $1.967b | | | | BioCryst Pharmaceuticals, Inc. designs and develops novel, oral and small-molecule medicines. Its drug candidates include Berotralstat, BCX9930, BCX9250, RAPIVAB, ALPIVAB, RAPIACTA, PERAMIFLU, Galidesivir and Mundesine. The company was founded in 1986 and is headquartered in Durham, NC. |